bibliographic entry 6949524 [be/6949524]
https://w3id.org/oc/corpus/be/6949524

is a

• bibliographic reference

content

• Takeda Pharmaceutical Company Limited. Efficacy and safety of alogliptin used in combination with α-glucosidase inhibitor in participants with type 2 diabetes in Japan. National Library of Medicine (US), 2000. https://clinicaltrials.gov/show/NCT01263483.

references

• https://w3id.org/oc/corpus/br/5659517